Pregled bibliografske jedinice broj: 1260312
Obesity as a comorbidity in children and adolescents with autoimmune rheumatic diseases
Obesity as a comorbidity in children and adolescents with autoimmune rheumatic diseases // Rheumatology international, 43 (2022), 2; 209-219 doi:10.1007/s00296-022-05238-6 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1260312 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Obesity as a comorbidity in children and adolescents
with autoimmune rheumatic diseases
Autori
Held, Martina ; Sestan, Mario ; Jelušić, Marija
Izvornik
Rheumatology international (0172-8172) 43
(2022), 2;
209-219
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Obesity ; Overweight ; Autoimmune diseases ; Rheumatic diseases ; Children ; Adolescents
Sažetak
Childhood obesity is the public health issue with alarming rates recorded throughout developed world and an important modifable health risk for developing various chronic diseases, with childhood-onset autoimmune rheumatic diseases among them also. The aim of this article was to summarize epidemiological, pathophysiological and clinical implication of obesity on juvenile idiopathic arthritis (JIA), childhood-onset systemic lupus erythematosus (cSLE), juvenile dermatomyositis (JDM), IgA vasculitis (IgAV) and Kawasaki disease (KD). We reviewed PubMed database and selected 74 relevant articles. Epidemiological data of obesity among children with autoimmune rheumatic diseases indicate an increased prevalence of it. Pathophysiological link between obesity, humoral adipokines and cytokines released from fat tissue and childhood-onset autoimmune rheumatic diseases is complex and still not entirely clear. From the clinical point of view, obesity was not associated with disease activity in JIA and cSLE, but proved to contribute on functional impairment in both diseases and affect poor treatment response in JIA patients. Early atherosclerosis and cardiovascular disease (CVD) development in obese children and adolescents with JIA, cSLE and JDM are certainly important obesity- related complications. Understanding how obesity afects children and adolescents with autoimmune rheumatic diseases may encourage clinicians to consider taking better preventive strategies in this population to improve their long-term outcome.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE